+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ceftriaxone"

Antibacterial Drugs Market Report 2024-2034 - Product Thumbnail Image

Antibacterial Drugs Market Report 2024-2034

  • Report
  • January 2024
  • 269 Pages
  • Global
From
Cephalosporin Global Market Report 2024 - Product Thumbnail Image

Cephalosporin Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
Urinary Tract Infection Treatment Global Market Report 2024 - Product Thumbnail Image

Urinary Tract Infection Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Research Report on China's Ceftriaxone Export 2023-2032 - Product Thumbnail Image

Research Report on China's Ceftriaxone Export 2023-2032

  • Report
  • January 2023
  • 50 Pages
  • China
From
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2023
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2023
  • 135 Pages
  • China
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Ceftriaxone is an antibiotic used to treat a wide range of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are used to treat infections caused by Gram-positive and Gram-negative bacteria. Ceftriaxone is commonly used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat meningitis, sepsis, and gonorrhea. Ceftriaxone is available in both intravenous and intramuscular forms, and is often used in combination with other antibiotics. The ceftriaxone market is driven by the increasing prevalence of bacterial infections, the growing demand for antibiotics, and the increasing availability of generic versions of the drug. The market is also driven by the increasing use of ceftriaxone in the treatment of multi-drug resistant infections. Some of the major companies in the ceftriaxone market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Show Less Read more